GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


ADVANCED QUANTITATIVE BENEFIT-RISK ASSESSMENT METHODS IN DECISION MAKING ON MEDICINES


Eu2P Certificate: Advanced quantitative benefit-risk assessment methods in decision making on medicines

OBJECTIVES

Decision making on medicines informed by quantitative benefit-risk assessment may differ depending on the perspective of the decision maker and the phase of drug development.

This module will address the decision-making on medicines by different stakeholders and how to apply advanced benefit-risk assessment tools in this process.

Applied decision making, individualized benefit-risk assessment, real life data, graphical representation

 

MODULE PARTS

  1. Multi-criteria decision analysis
  2. Conjoint analysis
  3. Personalized benefit-risk assessment

 

TRAINER TEAM

Coordinator: Satu Siiskonen (from Universiteit Utrecht)

Expert(s): Prof Olaf Klungel, Dr Rianne Van Den Ham, Dr Jet Van Der Zijden, Dr Tjeerd Van Staa, Dr Rob Heerdink, Prof Anke Hilse Maitland - Van Der Zee (from Universiteit Utrecht), Dr George Quartey (from F. Hoffmann-La Roche Ltd), Dr Filip Mussen (from Janssen Pharmaceutica NV), Dr Hans Hillege, Dr Douwe Postmus (from University Medical Centre Groningen).

Advanced level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 or PhD programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

Applications currently closed

Application to this training will be available
from June 21st, 2021 to March 27th, 2022.
Thanks for applying during this period.

Contact the Eu2P Central Office

Applications will open on June 21st, 2021. Please contact the Eu2P Central Office for information.

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 6 30 29 00 29

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners